Stroke Trial, Recruiting NCT04130503 Sponsor: Yale University Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT04130503
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had an acute ischemic stroke (a stroke caused by a blocked blood vessel) confirmed by a brain scan within 48 hours of their symptoms starting
  • People who are within 5 days of when their stroke symptoms first began
  • People who have been found to have moderate or severe obstructive sleep apnea (a condition where breathing repeatedly stops and starts during sleep), based on a sleep test showing a score of 15 or higher on a breathing disruption scale

Who may not be able to join:

  • People who have previously been prescribed a PAP machine (a breathing device used during sleep for sleep apnea)
  • People suspected of having a sleep disorder other than obstructive sleep apnea, such as narcolepsy
  • People whose life expectancy is less than 6 months, such as those in hospice care
  • People who currently require a mechanical ventilator (a machine that breathes for them)
  • People who do not speak English, as the study involves building an ongoing relationship with research staff through conversation
  • People whose sleep breathing issues are mostly classified as central sleep apnea (a type where the brain does not send the right signals to breathing muscles), specifically where more than half of breathing events are of this type
  • People whose blood oxygen level at rest is below 90%
  • People who are not able to give their own informed consent to participate in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Klar Yaggi, MD, MPH, Yale University

Phone: 2033614037

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
1 September 2019
Est. completion
1 October 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Modified Rankin Scale (mRS); Change in Katz Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov